Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pertussis vaccines: present status.

M Christodoulides1

  • 1Department of Pathology, Royal Victoria Infirmary, University of Newcastle-upon-Tyne, England.

Advances in Biotechnological Processes
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pattern recognition receptors in microbial keratitis.

Eye (London, England)·2015
Same author

Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: a 3-year cross-sectional population based analysis.

Vaccine·2013
Same author

Effective plasmid DNA and small interfering RNA delivery to diseased human brain microvascular endothelial cells.

Journal of molecular microbiology and biotechnology·2012
Same author

Recombinant proteins in vaccine development.

Methods in molecular medicine·2011
Same author

Epitope mapping.

Methods in molecular medicine·2011
Same author

Identification of novel pneumolysin alleles from paediatric carriage isolates of Streptococcus pneumoniae.

Journal of medical microbiology·2010
Same journal

Bacterial vaccines.

Advances in biotechnological processes·1990
Same journal

Baculovirus expression vector system for production of viral vaccines.

Advances in biotechnological processes·1990
Same journal

Subunit vaccines against infection by enveloped viruses.

Advances in biotechnological processes·1990
Same journal

World Health Organization attitude concerning the use of continuous cell lines as substrates for production of human virus vaccines.

Advances in biotechnological processes·1990
Same journal

Rabies vaccines from Pasteur's time up to experimental subunit vaccines today.

Advances in biotechnological processes·1990
Same journal

Vaccines against viruses associated with diseases in human central nervous system.

Advances in biotechnological processes·1990
See all related articles

Pertussis (whooping cough) remains a global threat, especially in areas lacking immunization. Acellular pertussis vaccines offer a safer, effective alternative to whole-cell vaccines, improving public confidence and disease control.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Pertussis (whooping cough) continues to cause significant mortality and morbidity globally, particularly in regions with limited mass immunization programs.
  • Whole-cell pertussis vaccines (WCPV) are effective but associated with infant reactogenicity, driving research into alternative formulations.
  • Achieving high immunization coverage is crucial for pertussis control.

Purpose of the Study:

  • To review the progress in developing and implementing acellular pertussis vaccines (aP).
  • To assess the safety and efficacy of aP compared to WCPV.
  • To discuss the future prospects of pertussis vaccine development for disease eradication.

Main Methods:

  • Review of recent advancements in acellular pertussis vaccine technology.

Related Experiment Videos

  • Analysis of clinical trial data and real-world usage of acellular pertussis vaccines.
  • Discussion of factors influencing vaccine production and public acceptance.

    • Main Results:

    • Acellular pertussis vaccines have been developed and are in routine use, demonstrating improved safety profiles for infants compared to WCPV.
    • Clinical studies in Japan, Sweden, and other countries indicate that acellular vaccines are as effective as conventional whole-cell vaccines in preventing pertussis.
    • Gene manipulation holds promise for future vaccine development, potentially enhancing public confidence.

    Conclusions:

    • Acellular pertussis vaccines represent a significant advancement, offering enhanced safety and comparable efficacy to whole-cell vaccines.
    • While acellular vaccines improve disease control, widespread use of conventional whole-cell pertussis vaccines may persist in some regions due to production and accessibility factors.
    • Future development of sophisticated acellular pertussis vaccines could pave the way for global pertussis eradication.